Integration of Antimicrobials and Delivery Systems: Synergistic Antibiofilm Activity with Biodegradable Nanoemulsions Incorporating Pseudopyronine Analogs

Author:

Park Jungmi1ORCID,Mahida Neel1,Ho Gabrielle1,Pena Elizabeth1,Makabenta Jessa Marie V.1ORCID,Aneke Stanley1,Jiang Mingdi1ORCID,Bouthillette Leah M.2,Holz Stephanie E.2,Hassan Muhammad Aamir1ORCID,Wolfe Amanda L.2ORCID,Rotello Vincent M.1ORCID

Affiliation:

1. Department of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003, USA

2. Department of Chemistry and Biochemistry, University of North Carolina Asheville, Asheville, NC 28804, USA

Abstract

Multi-drug-resistant (MDR) bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), pose a significant challenge in healthcare settings. Small molecule antimicrobials (SMAs) such as α-pyrones have shown promise as alternative treatments for MDR infections. However, the hydrophobic nature of many SMAs limits their solubility and efficacy in complex biological environments. In this study, we encapsulated pseudopyronine analogs (PAs) in biodegradable polymer nanoemulsions (BNEs) for efficient eradication of biofilms. We evaluated a series of PAs with varied alkyl chain lengths and examined their antimicrobial activity against Gram-positive pathogens (S. aureus, MRSA, and B. subtilis). The selected PA with the most potent antibiofilm activity was incorporated into BNEs for enhanced solubility and penetration into the EPS matrix (PA-BNEs). The antimicrobial efficacy of PA-BNEs was assessed against biofilms of Gram-positive strains. The BNEs facilitated the solubilization and effective delivery of the PA deep into the biofilm matrix, addressing the limitations of hydrophobic SMAs. Our findings demonstrated that the PA2 exhibited synergistic antibiofilm activity when it was loaded into nanoemulsions. This study presents a promising platform for addressing MDR infections by combining pseudopyronine analogs with antimicrobial biodegradable nanoemulsions, overcoming challenges associated with treating biofilm infections.

Funder

Research Corporation for Science Advancement, North Carolina Biotechnology Center

esearch Corporation for Science Advancement Cottrell Scholar Award

National Institutes of Health

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference38 articles.

1. CDC (2019). Antibiotic Resistance Threats in The United States 2019.

2. Richardson, L.A. (2017). Understanding and Overcoming Antibiotic Resistance. PLoS Biol., 15.

3. The Antibiotic Resistance Crisis: Part 1: Causes and Threats;Ventola;Pharm. Ther.,2015

4. Bacterial Biofilm and Associated Infections;Jamal;J. Chin. Med. Assoc.,2018

5. Multidrug Resistance in Bacteria;Nikaido;Annu. Rev. Biochem.,2009

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3